WHO ICTRP trial
Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated…
JPRN-jRCT2080222305 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080222305 |
|---|---|
| Public title | Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration) |
| Scientific title | Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration) |
| Primary sponsor | Taisho Pharmaceutical co., LTD |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Healthy Japanese male subjects |
| Interventions | investigational material(s) Generic name etc : TS-071 INN of investigational material : luseogliflozin Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral control material(s)… |
| Registration date | Nov 21, 2013 |
| Target size | 24 |
| Secondary IDs | JapicCTI-132354 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: